BridgeBio Oncology Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
BBOT•BridgeBio Oncology Therapeutics reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
1. Inducement grants
BridgeBio Oncology Therapeutics reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
